statistically significant for artemisinin-based combination therapy). The authors find that these increases in the coverage of efficacious malaria interventions were accompanied by an annual risk of under-five death that declined 15% more in the Initiative's partner countries compared with neighboring countries following the Initiative's implementation. These are striking findings.
Are these findings plausible in the context of evidence on aid effectiveness? One of the vexing dilemmas of foreign aid is that the "hydraulic" model (more in, more out) often fails empirical scrutiny, even when it is intended for efficacious interventions [5] . Efficacy (having a benefit in a trial setting) is commonly different from effectiveness (having a benefit in realworld context), and the efficacy-effectiveness gap is the bane of many working in global health and development [10] . Three features distinguish effective health aid: it (i) supports large programs (ii) that finance highly efficacious interventions (iii) in populations with high-burden and low-met need. This was the landscape for malaria when the US President's Malaria Initiative started. After frequently successful efforts to control the Anopheles vector in the 1950s and 1960s, often using DDT, malaria control programs retreated and the epidemic took hold across most of sub-Saharan Africa [11] . National malaria control programs were chronically underfunded, especially in high-burden regions. The malaria mortality curve bent downward only after the resurgence of attention to the epidemiology, the development of low-cost insecticidetreated nets and artemisinin-based therapies, and the commitment by large foreign aid organizations.
The motto of the US Agency for International Development, pasted on every USAIDfinanced clinic, is "From the American People." The American people do indeed fund USAID -about 1% of US government revenue goes to foreign aid. But the American people also benefit from the successes of foreign aid for health. Averting deaths of young children from malaria or vaccine-preventable diseases such as polio or measles promotes more stable and prosperous societies. In countries where the US gives most for health, the perception of the United States is among the most favorable in the world. For example, results from Pew Research Center Global Attitudes & Trends surveys show that in Ghana and Kenya, two partner countries for malaria and other forms of health aid, the portion of the population that views the US favorably approaches 90%, higher than in any European country (higher even than in the US) [12] . Finally, the economic benefits from reducing the burden of malaria are substantial, and some of those benefits are likely to return to the US [13] .
The evidence in the study by Jakubowski and colleagues is the first demonstration of the large-scale effectiveness of foreign aid for malaria control, and it joins the canon supporting health aid effectiveness. It also underscores that the anticipated benefits of effective aid include not only a reduction in the number of children dying in poor countries, but also, arguably, an investment in the well-being of Americans.
